The leaders in the human immune system
You. You drive us forward.
Our mission is to predict, prevent, reverse and cure diseases of the immune system. Our vision--a healthy immune system for everyone. Every person in the world. And we want to connect with you. You who have a disease(s) of the immune system. You who want to use our expertise. You who want to work with us. You who want to learn more. Give more. You who want to amplify who we are and what we do.
RNA Velocity Tregs treated with IL-2 Mutein
Collaborate with us
One of our core values is collaboration. We partner with scientists around the world, sharing our technology, biorepositories and expertise. Work with us to advance science and change lives.
COVID-19 mRNA Vaccination Does Not Promote Autoantibody Development
Read MoreNew Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells
Learn more ➡
New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells
Read More
Powering Possibility
Your support fuels groundbreaking discoveries and life-changing care. Philanthropy backs researchers who want to ask bold questions and get big answers that will change our understanding of the human immune system.
March 29, 2023
Learning How Tregs Keep Your Immune System in Check
The immune system keeps us healthy by maintaining a delicate balance. Every cell has a purpose: Some sound the alarm when they see an invader. Some attack germs that don’t belong. And some patrol the other cells in the immune system to make sure they’re doing their job.
March 14, 2023
Prediction and Prevention: A New Paradigm in Autoimmune Disease
The FDA recently approved teplizumab, a groundbreaking therapy that signals a paradigm shift in treating not only T1D but all autoimmune diseases.
March 14, 2023
Computer Science Reveals Possible Drug Target for Deadly Childhood Leukemia
Dr. Bolouri is an expert in using computer science to advance biomedical research. Working with Soheil Meshinchi, MD, PhD, and his team at Fred Hutch Cancer Center, they made a recent discovery that may lead to new treatments for certain forms of pediatric acute myeloid leukemia (AML).
Immuno-what? Hear the latest from BRI
Keep up to date on our latest research, new clinical trials and exciting publications.
